The hMSC Standard In The Ivory Tower
By Jessica Snyder

Living cells must be commercially available as a predictable raw material for future breakthroughs in the cellular therapy community and the rapidly maturing field of regenerative medicine. Industrialized quality control establishes a reliable process between researcher, regulator, and clinician. In addition to safety and efficacy in experimental trials, cellular manufacturing must be cleared of bottlenecks to meet demand on a commercial scale.
We accepted the challenge and built a business to enable a system of high quality and scalable volumes (billions) of human mesenchymal stromal cells (hMSC), paired media systems, and Good Manufacturing Practice (GMP) bioprocess expertise. But, did it work?
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.